"Designing Growth Strategies is in our DNA"
Neurology endoscopy or neuroendoscopy devices refer to medical devices that allow the application of endoscope for the treatment and diagnosis of the disorders of the central nervous system. Neurology endoscopy devices allow for the undertaking of minimally invasive operations, often with the assistance of a small hole and or in combination with the endoscope-assisted surgical microscope. Neurology endoscopy devices are both diagnostic and operative in nature and can aid in the treatment of several neurological disorders such as hydrocephalus, cerebral aneurysms, neurocysticercosis, colloid cyst and minimally invasive brain & spinal cord injuries.
Neurology endoscopy devices apart from being minimally invasive, leading to lower blood loss and risk of infections, which leads to faster recovery periods and shorter hospital stays. Neurology endoscopy devices help the performing of surgeries relatively easier than before due to increased light intensity while approaching the object, clear depiction of details in close up & extended viewing angle but certain precautions such as high degree of precision required from the medical professionals are required. These trends are expected to lead to the positive growth of the global neurology endoscopy devices market.
To get information on various segments, share your queries with us
The global neurology endoscopy devices market is anticipated to grow, owing to a number of factors such as increased prevalence of neurological disorders like Parkinson’s Disease, Alzheimer’s Disease and brain tumors, increasing geriatric population, increasing demand for minimally invasive surgeries, technological advancements in the devices, increase in neurological surgical procedures, lower risk of infections and shorter hospital stays, high degree of precision in the procedures undertaken and rising demand for preventive care.
According to the studies by the American Society for Clinical Oncology (ASCO), it was estimated in the year 2017, 23,880 individuals in the U.S. will be diagnosed with primary cancers of the brain and spinal cord. The Parkinson’s Foundation estimates that every year, approximately 60,000 individuals are diagnosed with Parkinson’s Disease in the U.S. These trends combined with the other factors are expected to positively drive the market growth.
The factors limiting the global neurology endoscopy devices are the safety concerns associated with neurology endoscopy devices, high cost of the devices and the dearth of skilled medical professionals.
Some of the major companies that are present in the global Neurology Endoscopy Devices market are Medtronic, Karl Storz SE & Co. KG, Medtronic, Johnson & Johnson Services, Inc., Olympus Corporation, C.R. Bard (Becton, Dickinson, and Company), Arthrex, Inc., HOYA Corporation, Boston Scientific Corporation and FUJIFILM Corporation, and others.
· Operative Devices
· Visualization Systems
By Disease Indication
· Brain Tumor
· Brain & Spinal Oncology
· Alzheimer’s Disease
· Parkinson’s Disease
· Nervous System Disorders
By End User
· Hospitals & Clinics
· Neurology Clinics
· Ambulatory Surgery Centers
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Among the segmentation, hospitals & clinics in the end user segment is projected to hold a considerable share of the global neurology endoscopy devices market due to a higher number of neurology procedures being undertaken in hospitals & clinics in developed as well as developing countries.
North America dominates the global neurology endoscopy devices market due to a number of factors such as the increasing prevalence of neurological diseases such as brain tumors and cancers, established healthcare system, high healthcare expenditure, access to advanced technologies and rising demand for minimally invasive procedures. The Asia Pacific is the fastest emerging market due to increasing incidences and awareness of neurological disorders, increasing access to advanced technologies, large population bases, high aging populace, increasing disposable incomes, increasing awareness and demand for minimally invasive procedures and developing healthcare systems.